1. Economic Impact and Complications of Treated and Untreated Hepatitis C Virus Patients in Turkey 
Onur Baser, MS, PhD, Akif Altinbas, MD, Erdem Baser, MS, M. Furaha Kariburyo, MPH 
Value in Health Regional Issues 
Volume 7, Pages (September 2015)
DOI: /j.vhri
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Patient selection criteria. HCV, hepatitis C virus; Peg-IFN-α, pegylated interferon-alpha.
Value in Health Regional Issues 2015 7, 42-48DOI: ( /j.vhri )
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions